Nakhia Impex LLC
9
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain: A Pilot Clinical Study
Role: lead
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic Nasopharyngitis: A Prospective Clinical Study
Role: lead
Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome
Role: lead
35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin
Role: lead
35kDa Hyaluronan Fragment Treatment of Colorectal and Rectal Cancer
Role: lead
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
Role: lead
A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer
Role: lead
Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds
Role: lead
A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain
Role: collaborator
All 9 trials loaded